Coala-life

Third quarter 2023

• Net sales increased to approximately SEK 14 M (5.0).
• EBITDA amounted to approximately SEK -30 M (-27.8).
• Operating income totaled approximately SEK -32 M (-28.2).
• Profit after tax was approximately SEK -31 M (-18.5).
• Cash flow from operating activities was approximately SEK -6 M (-36.1).

The period: January 1, 2023 – September 30, 2023

• Net sales increased to approximately SEK 40 M (7.5).
• EBITDA amounted to approximately SEK -90 M (-99.4).
• Operating income totaled approximately SEK -97 M (-101.7).
• Profit after tax was approximately SEK -94 M (-88.6).
• Cash flow from operating activities was approximately SEK -65 M (-122.5).

Key figures for October 2023:

• Patients in RPM as of October 31, 2023: 4,400
• Annual revenue rate as of October 31, 2023: USD 4.6 MUSD

Explanations of KPI´s
Patients in RPM as of October 31, 2023 – Number of patients that the company monitors in USA at the end of October.
Annual revenue rate as of October 31, 2023 – Estimated recurring revenue in USD based on October month’s revenue, measured at an annual rate.

Comments of KPI´s October 2023

The number of patients is unchanged compared to previous periods. Reveneus was however exceptionally affected in October due to a large number of patients not taking their measurements, which led to a large decrease in the number of measurements that could be invoiced. The company works actively to increase the compliance.

Historical KPI´s

The figures in this press release are preliminary and unaudited.